Dr Kezia Rajappa
Dr. Kezia Blessinda Rajappa is a distinguished Clinical Biochemist and academic with a strong foundation in medical biochemistry, teaching, and research. She is currently a Lecturer in Clinical Biochemistry at Westminster University. Dr. Rajappa holds an MBBS from Dr. Somervell Memorial CSI Medical College and an MD in Medical Biochemistry from Sree Gokulam Medical College & Research Foundation in Kerala, India. Additionally, she has completed a Postgraduate Diploma in Family Medicine from the Royal College of General Practitioners (RCGP), UK.
Dr . Rajappa's expertise spans clinical biochemistry, laboratory medicine, and biomarker research. Her professional journey has taken her from being a Medical Intern in India to an academic and clinical scientist in the UK(HCPC registered). Her work is marked by a commitment to education and advancing scientific understanding in her field.
Dr. Kezia Rajappa has an extensive publication and research record, with a primary focus on diabetes, biomarkers, metabolic diseases, and inflammation. Her peer-reviewed articles in national and international journals include:
"Relationship Between Serum HbA1C Level with CRP Level in Patients with Diabetic Foot Ulcer and Newly Detected Diabetes Mellitus" (Journal of Medical Science and Clinical Research, 2019).
"Relationship Between Serum Transaminases and Serum Neopterin in Type 2 Diabetes Mellitus" (Innovative Journal of Medical and Health Science, 2021).
"Insulin Resistance and Lipoprotein Metabolizing Enzymes in Response to a Fatty Meal in Type 2 Diabetes Mellitus" (IJMSCR, 2021).
"Establishing Reference Intervals for Lipid Profile in Healthy Adults" (International Journal of Scientific Research, 2021).
"Hemochromatosis Presenting with Diabetes Mellitus & Hypogonadism" (Innovative Journal of Medical and Health Science, 2021).
"Serum Neopterin as an Inflammatory Marker in Diabetic Foot Ulcers" (IJMSCR, 2023).
Her research contributions span various clinically relevant topics, including inflammatory markers in diabetic complications, improving laboratory diagnostic accuracy through pre-analytical error audits, and investigating metabolic risk factors in carcinoma breast. Dr. Rajappa's work reflects her commitment to advancing laboratory medicine and enhancing clinical outcomes through research-driven practices.